Belgian biopharmaceutical group with its head office in Brussels, founded in 1928 as Union Chimique Belge and listed in Brussels, working in about forty countries. Develops, makes and sells medicines for severe diseases of the nervous and immune systems, with antiepileptics such as levetiracetam and brivaracetam, treatments for myasthenia gravis and Parkinson's disease, and biologic antibodies in psoriasis, rheumatology and bone disease, and runs its own research, biologics and finished dose manufacturing, clinical development and pharmacovigilance.
No comments available.
Leave your rating & comment